Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Criminal Law topic
No spam. Unsubscribe anytime.
House raises penalties for driving with controlled substances; debate centers on active THC testing and causation
Summary
The House approved SB 51 to increase penalties for driving with certain controlled substances in the body, prompting extended floor debate about causation, active THC versus metabolites, secondhand exposure and the testing standards that would be used in prosecutions.
The Utah House passed Senate Bill 51, which raises penalties for operating a vehicle with certain controlled substances in the body and clarifies how different drug schedules are treated under state law.
Representative Ray, sponsor of the amendments, said the bill moves marijuana (THC) from a class A misdemeanor toward a higher felony classification when active THC is detected and in cases that cause serious bodily injury or death. He repeatedly emphasized the distinction between active THC and metabolites that can remain detectable in the body for days or weeks: "Realize what we're talking about, first of all, it's active THC. It's recently used. It's not 3 days old. That's the metabolites of THC," Ray said.
Several members pressed the sponsor on causation and due-process protections: Representative Christiansen and others asked whether the statute preserves safeguards so prosecutors must show a causal link between impairment and an accident rather than merely the presence of prior drug use. Ray responded that the measure targets active THC and the testing mechanism (blood tests) that identify recent use, and that the bill is not intended to penalize remote past use.
Other questions addressed secondhand smoke, prison bed impacts, and the distinction between Schedule I/II substances (treated as second‑degree felonies in the bill) and lower schedules (treated as misdemeanors). The sponsor said no fiscal note anticipated significant increases to incarceration because most cases would be diverted to treatment or resolved in plea negotiations.
The House closed voting and the Clerk reported the bill received 71 yes, 1 no, 3 absent; the bill passed and will be returned to the Senate for the president’s signature.
Supporters described the measure as providing prosecutors with additional tools to pursue serious cases involving drug-impaired driving; critics urged care to preserve due-process protections and to avoid penalizing residual metabolites or exposure that did not cause impairment.
